Cargando…
Osteoporosis in men: epidemiology and treatment with denosumab
Osteoporosis is a major public health care concern. Although often described as a disease affecting postmenopausal women, researchers and clinicians have emphasized its prevalence in men in recent years. The National Osteoporosis Foundation has stated that up to 25% of men over the age of 50 years w...
Autores principales: | Sidlauskas, Kristel M, Sutton, Emily E, Biddle, Michael A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986279/ https://www.ncbi.nlm.nih.gov/pubmed/24748777 http://dx.doi.org/10.2147/CIA.S51940 |
Ejemplares similares
-
Denosumab for the treatment of osteoporosis
por: McClung, Michael R.
Publicado: (2017) -
Denosumab, an effective osteoporosis treatment option for men
por: Kong, Sung Hye
Publicado: (2022) -
Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2011) -
A review of denosumab for the treatment of osteoporosis
por: Miyazaki, Tsuyoshi, et al.
Publicado: (2014) -
Should denosumab treatment for osteoporosis be continued indefinitely?
por: Noble, Jane A., et al.
Publicado: (2021)